目的 研究巩膜外垫压手术联合视网膜激光光凝对硅油眼视网膜脱离的治疗效果。 方法 回顾性分析2009年1月－2012年1月，用巩膜外垫压联合视网膜光凝手术治疗36例硅油眼视网膜脱离的视网膜复位效果。 结果 全部患者均顺利完成巩膜外垫压手术及随后的视网膜激光光凝，行巩膜外放液5只眼，手术中未发生视网膜嵌顿、眼内出血和眼压显著升高等并发症；手术后1周视网膜复位21只眼（58.33%），剩下15只眼1个月后复位7只眼（19.44%），视网膜脱离总复位率为28只眼（77.77%）；未复位8只眼（22.23%），改用玻璃体切割手术方式，视网膜成功复位；6个月后取出硅油，随访6个月视网膜无脱离或者脱离范围增加；手术后眼压≥30 mm Hg （1 mm Hg=0.133 kPa）3只眼，≥20 mm Hg 7只眼，对症治疗1周后眼压均恢复到正常范围。 结论 巩膜外垫压联合视网膜激光光凝治疗硅油眼视网膜脱离，手术简单，复位率高，可为硅油眼视网膜脱离首选手术方式，对于巩膜外垫压手术失败和复杂的硅油眼视网膜脱离，应当选择玻璃体切割手术方式。
ObjectiveTo investigate the association of high density lipoprotein cholesterol (HDL-C) and cholesterol ester transfer protein (CETP) TaqIB mutation with non-arteritic anterior ischemic optic neuropathy (NA-AION) in the Shaanxi Han ethnic population. MethodsThe study cohort consisted of 45 individuals that had been diagnosed with NA-AION and 45 healthy controls (matched for age, gender). None of the cases or controls had a history of diabetes, serious cardio-cerebral vascular diseases, liver and kidney dysfunction that might influence plasma lipid levels. Plasma HDL-C was detected by enzyme-linked immunosorbent one-step, through the Toshiba TBA-40FR automatic biochemical analyzer. CETP TaqIB gene polymorphism was determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) techniques for analysis. B2B2 genotype was only a fluorescence band with 535 bp; B1B1 genotype was 2 fluorescence bands with 361, 174 bp; B1B2 genotype was 3 fluorescence bands with 535, 361, 174 bp. The relative risk of genotype, HDL-C and disease occurrence was analyzed by logistics regression analysis. ResultsThere have no significant difference between NA-AION patients and controls about plasma total cholesterol level and triglyceride level (t=1.907, 1.877; P > 0.05). The plasma HDL-C levels were significantly lower in NA-AION patients than in controls (t=2.367, P=0.022). Compared with controls, the prevalence of B1B1 genotype and B1 allele was higher (χ2=17.289, P=0.001), the prevalence of B2 allele (χ2=15.648, P=0.000) was lower in NA-AION patients. The lower concentration of HDL-C was risk factor of NA-AION (odds ratio=6.143, 95% confidence interval 1.262-29.895, χ2=27.676;P=0.013). The proportion of B1B1 genotype was significantly higher in NA-AION patients than in controls (odds ratio=2.24, 95% confidence interval 2.427-36.323, χ2=10.526; P=0.001). ConclusionsThe low plasma HDL-C is independent risk factor for NA-AION and is associated with the development of NA-AION in the Shaanxi Han ethnic population. CETP TaqIB mutation is associated with low plasma HDL-C in NA-AION in the Shaanxi Han ethnic population.
目的探讨腹腔镜下不同的入肝血流阻断方法下行规则性或不规则性局部肝切除的手术方法及其临床应用。 方法回顾性分析2007年5月至2012年7月期间在江苏省苏北人民医院完成的25例腹腔镜肝切除术患者的临床资料，其中行规则性肝切除术14例，不规则性局部肝切除术11例。术后病理学检查证实原发性肝癌9例，肝血管瘤10例，结直肠癌肝转移1例，左肝内胆管结石5例。 结果本组25例均成功完成了腹腔镜肝切除术（其中合并胆囊切除术3例，合并胆囊切除及胆总管探查术1例），无中转开腹手术者。其中行区域性入肝血流阻断联合规则性肝切除术14例，应用自制的第一肝门阻断器行全肝入肝血流阻断联合不规则的局部肝切除术11例。手术时间（149.6±19.8）min（120～195 min），术中出血量（320±73.6）mL（180～460 mL），腹腔引流管放置时间3～11 d。有1例术后第3天出现胆汁漏，予以放置自制双套管冲洗后引流量逐渐减少，术后第11天顺利拔管；其余病例未发生胆汁漏、出血、感染等并发症。术后住院时间（8.6±2.4）d（5～13 d）。9例肝脏恶性肿瘤患者术后均获随访，截至2012年7月29日，其随访时间12～48个月，平均17个月，1年无瘤生存患者有7例。 结论腹腔镜肝切除术是安全可行的，肝脏血流阻断技术是其成功的关键和保障。左半肝或左外叶病灶可考虑行区域性入肝血流阻断联合规则性肝切除术；右半肝不规则的病灶或病灶较小时，应用自制的第一肝门阻断器行全肝入肝血流阻断联合不规则的局部肝切除术，是简洁、实用的方法，可避免切除过多的肝组织。